Recent investigations with a mouse in vivo xenograft model further substantiated the inhibitory role of USF2 since overexpression of USF2 in prostate cancer cells inhibited the tumorigenicity of these cells (Chen et al., 2006). This evidence concerns the gene USF2 and Familial prostate cancer.